Vimian Group AB (publ)
General ticker "VIMGF" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $1.9B (TTM average)
Vimian Group AB (publ) does not follow the US Stock Market performance with the rate: -44.6%.
Estimated limits based on current volatility of 0.0%: low 2.77$, high 2.77$
Short-term VIMGF quotes
Long-term VIMGF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €331.73MM | €374.80MM | €425.00MM |
| Operating Expenses | €290.46MM | €325.60MM | €357.40MM |
| Operating Income | €41.27MM | €49.20MM | €67.60MM |
| Non-Operating Income | €-21.82MM | €-20.40MM | €-21.70MM |
| Interest Expense | €19.25MM | €25.40MM | €21.10MM |
| R&D Expense | €5.67MM | €0.00MM | €0.00MM |
| Income(Loss) | €19.45MM | €28.80MM | €45.90MM |
| Taxes | €8.96MM | €9.50MM | €13.50MM |
| Profit(Loss)* | €9.84MM | €18.50MM | €31.30MM |
| Stockholders Equity | €526.37MM | €699.90MM | €698.90MM |
| Inventory | €60.29MM | €78.40MM | €80.10MM |
| Assets | €973.68MM | €1,109.80MM | €1,109.80MM |
| Operating Cash Flow | €-28.58MM | €58.10MM | €105.70MM |
| Capital expenditure | €14.90MM | €14.20MM | €15.10MM |
| Investing Cash Flow | €-77.68MM | €-76.00MM | €-112.80MM |
| Financing Cash Flow | €100.55MM | €44.80MM | €-1.20MM |
| Earnings Per Share** | €0.02 | €0.04 | €0.06 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.